Research
Bioinspired and Data-Driven Nanomedicine for Cancer Immunotheranostics
The Kenry Lab was established in June 2023 at the University of Arizona, and comprises a highly interdisciplinary team of pharmaceutical, biomedical, and data scientists and engineers who are motivated to improve patient outcomes and health by addressing various unmet needs in cancer diagnosis and therapy.
Leveraging our expertise in nanomaterials, microfluidics, bioimaging, immunotherapy, and machine learning, we adopt bioinspired and data-driven approaches to build novel platform tools and models to control immune system in the quest to achieve more personalized, targeted, and safer detection and treatment of cancer.
Research Areas
Nano-Immuno Interactions
We systematically interrogate the interactions between the immune system and theranostic nanomaterials to enhance their targeting specificity, theranostic efficacy, and safety profile.
Bioinspired Immunotheranostics
We leverage different biologically inspired technologies, such as cell membrane coating and microfluidics, to develop novel platform tools to improve cancer immunotheranostics.
Machine Learning
We build machine learning models to streamline the engineering of novel theranostic agents. We also integrate machine learning with bioimaging and biosensing to realize more rapid and accurate cancer diagnosis.
Research Funding and Support
